BOSTON BIO SYSTEMS LTD. Complete Financial Statements
BOSTONBIO • Review detailed financials to uncover trends, confirm thesis & journal trades
8 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for BOSTON BIO SYSTEMS LTD. (BOSTONBIO).
Downloads include all available records across all periods.
Profitability Ratios
Operating Margin
-284.00%
2025 data
Return on Assets
-6.67%
2025 data
Return on Equity
-16.67%
2025 data
Balance Sheet Ratios
Current Ratio
1.80
2025 data
Debt to Equity
2.50
2025 data
Equity Ratio
40.00%
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
EBITDA Growth
+100.0%
Year-over-Year
Assets Growth
+36.4%
Year-over-Year
Equity Growth
-14.3%
Year-over-Year
Liabilities Growth
+36.4%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
| EBITDA | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | -33.00% | -284.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | -0.60 | -0.78 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Related Pages for BOSTON BIO SYSTEMS LTD.
Additional stock information and data for BOSTONBIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| Current Assets | 9 | 5 | 5 | 5 | 4 | 4 | 3 | 1 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| LIABILITIES | ||||||||
| Total Liabilities | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| Current Liabilities | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Financing Activities | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |